KROIN DAVID
Insider CIK 1397513 · DVAX 10% owner · CNXR 10% owner · ADMS 10% owner · FOMX · LBRX 10% owner · ATTO 10% owner · NKTR 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATTO Attovia Therapeutics, Inc. | C Conversion deriv | 2026-08-06 | 2026-08-10 | 18,181,818 | — | $0 | 0 | SEC↗ |
| ATTO Attovia Therapeutics, Inc. | C Conversion | 2026-08-06 | 2026-08-10 | 1,957,138 | — | $0 | 1,957,138 | SEC↗ |
| ATTO Attovia Therapeutics, Inc. | C Conversion deriv | 2026-08-06 | 2026-08-10 | 18,181,818 | — | $0 | — | SEC↗ |
| ATTO Attovia Therapeutics, Inc. | C Conversion | 2026-08-06 | 2026-08-10 | 1,957,138 | — | — | 1,957,138 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | P Buy deriv | 2026-07-30 | 2026-08-03 | 286,205 | $34.94 | $10.00M | 664,649 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | P Buy deriv | 2026-07-30 | 2026-08-03 | 286,205 | $34.94 | $10.00M | 664,649 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | U Tender | 2026-02-10 | 2026-02-11 | 15,726,349 | — | $0 | 0 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | P Buy deriv | 2026-02-06 | 2026-02-10 | 378,444 | $21.17 | $8.01M | 378,444 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | P Buy deriv | 2026-02-06 | 2026-02-10 | 93,925 | $21.17 | $1.99M | 93,925 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | C Conversion deriv | 2025-09-12 | 2025-09-16 | 16,666,667 | — | $0 | 0 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | P Buy | 2025-09-12 | 2025-09-16 | 666,666 | $15.00 | $10.00M | 666,666 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | P Buy | 2025-09-12 | 2025-09-16 | 2,000,000 | $15.00 | $30.00M | 2,686,138 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | C Conversion | 2025-09-12 | 2025-09-16 | 686,138 | — | $0 | 686,138 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | S Sale | 2025-08-22 | 2025-08-22 | 970,143 | $10.59 | $10.27M | 15,726,349 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | S Sale | 2025-08-21 | 2025-08-22 | 1,094,994 | $11.03 | $12.08M | 16,696,492 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | S Sale | 2024-05-10 | 2024-05-13 | 56,000 | $1.78 | $99.7K | 18,344,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2017-06-21 | 2017-06-21 | 10,000 | $17.44 | $174.4K | 2,216,351 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2017-06-20 | 2017-06-21 | 20,000 | $17.35 | $347.0K | 2,231,351 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2017-06-19 | 2017-06-21 | 350,000 | $17.05 | $5.97M | 2,251,351 | SEC↗ |
| CNXR CONNECTURE INC | G Gift | 2015-06-30 | 2015-07-16 | 10,000 | — | $0 | 29,703 | SEC↗ |
| CNXR CONNECTURE INC | J Other | 2015-06-10 | 2015-06-12 | 1,375,733 | — | $0 | 4,127,232 | SEC↗ |
| CNXR CONNECTURE INC | J Other | 2015-06-10 | 2015-06-12 | 28,696 | — | $0 | 28,696 | SEC↗ |
| CNXR CONNECTURE INC | J Other | 2015-06-10 | 2015-06-12 | 36,493 | — | $0 | 36,493 | SEC↗ |
| CNXR CONNECTURE INC | J Other | 2015-06-10 | 2015-06-12 | 47,235 | — | $0 | 47,235 | SEC↗ |
| CNXR CONNECTURE INC | J Other | 2015-06-10 | 2015-06-12 | 39,703 | — | $0 | 39,703 | SEC↗ |
| CNXR CONNECTURE INC | C Conversion deriv | 2014-12-17 | 2014-12-17 | 17,696,553 | — | $0 | 0 | SEC↗ |
| CNXR CONNECTURE INC | S Sale | 2014-12-17 | 2014-12-17 | 395,886 | $8.00 | $3.17M | 5,502,965 | SEC↗ |
| CNXR CONNECTURE INC | C Conversion | 2014-12-17 | 2014-12-17 | 5,898,851 | — | $0 | 5,898,851 | SEC↗ |